Scynexis (SCYX) Asset Utilization Ratio (2014 - 2026)

Scynexis (SCYX) posted Asset Utilization Ratio of 0.3 for Q1 2026, down 20.44% on a QoQ basis from 0.37 in Q4 2025, and up 797.53% year-over-year from 0.03 in Q1 2025.

Scynexis (SCYX) Asset Utilization Ratio (2014 - 2026) Analysis & Trends

Scynexis' Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.3 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 797.53% year-over-year to 0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.3 (up 797.53% YoY) and the FY2025 annual result came in at 0.28, up 704.89% from the prior year.
  • Asset Utilization Ratio was 0.3 for Q1 2026 at Scynexis, down from 0.37 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.21 in Q2 2023 and bottomed at 0.02 in Q1 2022.
  • A 5-year average of 0.32 and a median of 0.07 in 2023 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2023 — Asset Utilization Ratio jumped 4649.18% — and 2025, when it tumbled 97.09%.
  • Scynexis' Asset Utilization Ratio stood at 0.05 in 2022, then jumped by 1883.8% to 1.01 in 2023, then tumbled by 96.1% to 0.04 in 2024, then soared by 847.47% to 0.37 in 2025, then fell by 20.44% to 0.3 in 2026.
  • Business Quant data shows SCYX's Asset Utilization Ratio at 0.3 in Q1 2026, 0.37 in Q4 2025, and 0.05 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.43
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.62
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.46
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 0.43
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 0.65
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.37
10 Scynexis 21.55 Mn -15.20 Mn - 0.30

Historic Data

Download Data
DateValue
Mar 31, 2026 0.30
Dec 31, 2025 0.37
Sep 30, 2025 0.05
Jun 30, 2025 0.05
Mar 31, 2025 0.03
Dec 31, 2024 0.04
Sep 30, 2024 0.08
Jun 30, 2024 0.09
Mar 31, 2024 1.14
Dec 31, 2023 1.01
Sep 30, 2023 0.90
Jun 30, 2023 1.21
Mar 31, 2023 0.07
Dec 31, 2022 0.05
Sep 30, 2022 0.03
Jun 30, 2022 0.03
Mar 31, 2022 0.02
Dec 31, 2021 0.11
Sep 30, 2021 0.11
Jun 30, 2021 0.11